We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

News   Jul 15, 2020 | Original story from Keck Medicine of USC

 
Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

Keck Medicine of USC physicians are participating in a clinical trial to evaluate the safety and efficacy of an antiviral drug, DAS181, as a possible treatment for hospitalized patients with severe COVID-19. Credit: Ricardo Carrasco III

 
 
Advertisement
 

RELATED ARTICLES

Most Effective Way To Detect SARS-CoV-2 in Wastewater Investigated

News

A group of researchers have demonstrated that, from seven methods commonly used to test for viruses in untreated wastewater, an adsorption-extraction technique can most efficiently detect SARS-CoV-2

READ MORE

Washington University COVID-19 Virus Effective in Mice

News

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis

READ MORE

Hydrogen Sulfide Reverses Antibiotic Resistance in Some Bacteria

News

A study has found that exposing bacteria to hydrogen sulfide can increase antimicrobial sensitivity in bacteria that do not produce H2S.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE